Antimycobacterial activity of salicylanilide benzenesulfonates

Molecules

Volumn 17, Issue 1, 2012, Pages 492-503

  Krátký, Martin ^a   Vinšová, Jarmila ^a   Rodriguez, Nabila Guisado ^a   Stolaríková, Jirina ^b  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^b Zdravotniho ustavu se sidlem v Ostrave   (Czech Republic)

Author keywords

Antimycobacterial activity; Benzenesulfonate; In vitro activity; Salicylanilide ester

Indexed keywords

ANTIINFECTIVE AGENT; BENZENESULFONIC ACID DERIVATIVE; ESTER; SALICYLANILIDE DERIVATIVE;

ARTICLE; CHEMICAL PHENOMENA; CHEMISTRY; DRUG DESIGN; DRUG EFFECT; ESTERIFICATION; MICROBIOLOGICAL EXAMINATION; MYCOBACTERIUM; SYNTHESIS;

ANTI-BACTERIAL AGENTS; BENZENESULFONATES; DRUG DESIGN; ESTERIFICATION; ESTERS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM; SALICYLANILIDES;

EID: 84856141351     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules17010492     Document Type: Article

References (23)

1. WHO. 2011/2012 Tuberculosis Global Facts. Available online: http://www.who.int/tb/ publications/2011/factsheet-tb-2011.pdf (accessed on 28 October 2011).
2. Vinsova, J.; Kratky, M. Development of New MDR-Tuberculosis Drugs, 1st ed.; Nova Science Publishers: New York, NY, USA, 2010; pp. ix-xii.
3. Kratky, M.; Vinsova, J. Advances in the Development of Antituberculotics Acting on Multidrug- Resistant Strains. Chem. Listy 2010, 104, 998-1005.
4. Sugita, A.; Ogawa, H.; Azuma, M.; Muto, S.; Honjo, A.; Yanagawa, H.; Nishioka, Y.; Tani, K.; Itai, A.; Sone, S. Antiallergic and anti-inflammatory effects of a novel IkB kinase b inhibitor, IMD-0354, in a mouse model of allergic inflammation. Int. Arch. Allergy Immunol. 2009, 148, 186-198.
5. Brown, M.E.; Fitzner, J.N.; Stevens, T.; Chin, W.; Wright, C.D.; Boyce, J.P. Salicylanilides: Selective inhibitors of interleukin-12p40 production. Bioorg. Med. Chem. 2008, 16, 8760-8764.
6. Zhong, G.X.; Chen, L.L.; Li, J.; Hu, W.X.; Qi, M.Y. Synthesis and anti-inflammatory-analgesic activity of 2',4'-difluoro-3-(carbamoyl)biphenyl-4- yl benzoates. Chin. Chem. Lett. 2008, 19, 1419-1422.
7. Calderone, V.; Coi, A.; Fiamingo, F.L.; Giorgi, I.; Leonardi, M.; Livi, O.; Martelli, A.; Martinotti, E. Structural modifications of benzanilide derivatives, effective potassium channel openers. X. Eur. J. Med. Chem. 2006, 41, 1421-1429. (Pubitemid 44895473)
8. Liechti, C.; Séquin, U.; Bold, G.; Furet, P.; Meyer, T.; Traxler, P. Salicylanilides as inhibitors of the protein tyrosine kinase epidermal growth factor receptor. Eur. J. Med. Chem. 2004, 39, 11-26. (Pubitemid 38251209)
9. Zhu, X.F.; Wang, J.S.; Cai, L.L.; Zeng, Y.X.; Yang, D. SUCI02 inhibits the erbB-2 tyrosine kinase receptor signaling pathway and arrests the cell cycle in G1 phase in breast cancer cells. Cancer Sci. 2006, 97, 84-89. (Pubitemid 43257032)
10. Krátký, M.; Vinšová, J. Antiviral Activity of Substituted Salicylanilides-A Review. Mini-Rev. Med. Chem. 2011, 11, 956-967.
11. Krátký, M.; Vinšová, J. Salicylanilide Ester Prodrugs as Potential Antimicrobial Agents- A Review. Curr. Pharm. Des. 2011, 17, 3494-3505.
12. Hamilton, W.A. Mechanism of the Bacteriostatic Action of Tetrachlorosalicylanilide- A Membrane Active Antibacterial Compound. J. Gen. Microbiol. 1968, 50, 441-458.
13. Terada, H.; Goto, S.; Yamamoto, K.; Takeuchi, I.; Hamada, Y.; Miyake, K. Structural requirements of salicylanilides for uncoupling activity in mitochondria: Quantitative analysis of structure-uncoupling relationships. Biochim. Biophys. Acta 1988, 936, 504-512. (Pubitemid 19002545)
14. Macielag, M.J.; Demers, J.P.; Fraga-Spano, S.A.; Hlasta, D.J.; Johnson, S.G.; Kanojia, R.M.; Russel, R.K.; Sui, Z.H.; Weidner-Wells, M.A.; Werblood, H.; et al. Substituted Salicylanilides as Inhibitors of Two-Component Regulatory Systems in Bacteria. J. Med. Chem. 1998, 41, 2939-2945. (Pubitemid 28359929)
15. Krátký, M.; Vinšová, J.; Buchta, V.; Horvati, K.; Bösze, S.; Stolaríková, J. New amino acid esters of salicylanilides active against MDR-TB and other microbes. Eur. J. Med. Chem. 2010, 45, 6106-6113.
16. Glowienke, S.; Frieauff, W.; Allmendinger, T.; Martus, H.J.; Suter, W.; Mueller, L. Structure- activity considerations and in vitro approaches to assess the genotoxicity of 19 methane-, benzene- and toluenesulfonic acid esters. Mutat. Res. 2005, 581, 23-34. (Pubitemid 40255891)
17. Imramovský, A.; Vinšová, J.; Férriz, J.M.; Doležal, R.; Jampílek, J.; Kaustová, J.; Kunc, F. New antituberculotics originated from salicylanilides with promising in vitro activity against atypical mycobacterial strains. Bioorg. Med. Chem. 2009, 17, 3572-3579.
18. Vinsova, J.; Imramovsky, A.; Buchta, V.; Ceckova, M.; Dolezal, M.; Staud, F.; Jampilek, J.; Kaustova, J. Salicylanilide Acetates: Synthesis and Antibacterial Evaluation. Molecules 2007, 12, 1-12.
19. Imramovský, A.; Férriz, J.M.; Pauk, K.; Krátký, M.; Vinšová, J. Synthetic route for the preparation of 2-hydroxy-N-[1-(2-hydroxyphenylamino)-1-oxoalkan-2-yl]benzamides. J. Comb. Chem. 2010, 12, 414-416.
20. Gwaltney, S.L.; Imade, H.M.; Li, Q.; Gehrke, L.; Credo, R.B.; Warner, R.B.; Lee, J.Y.; Kovar, P.; Frost, D.; Ng, S.C.; Sham, H.L. Novel Sulfonate Derivatives: Potent Antimitotic Agents. Bioorg. Med. Chem. Lett. 2001, 11, 1671-1673. (Pubitemid 32568294)
21. Waisser, K.; Bureš, O.; Holý, P.; Kuneš, J.; Oswald, R.; Jirásková, L.; Pour, M.; Klimešová, V.; Kubicová, L.; Kaustová, J. Relationship between the structure and antimycobacterial activity of substituted salicylanilides, Arch. Pharm. Pharm. Med. Chem. 2003, 1, 53-71. (Pubitemid 36402625)
22. Ferriz, J.M.; Vávrová, K.; Kunc, F.; Imramovský, A.; Stolaríková, J.; Vavríková, E.; Vinšová, J. Salicylanilide carbamates: Antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains. Bioorg. Med. Chem. 2010, 18, 1054-1061.
23. Kaustová, J. Quantitative micromethod for drug susceptibility testing of mycobacteria in Šulás medium. Klin. Microbiol. Inf. Lek. 1997, 3, 115-124.